Le Lézard
Classified in: Transportation, Health, Science and technology
Subject: PDT

DB HiTek Advances Global Shutter and SPAD


SEOUL, South Korea, June 3, 2024 /PRNewswire/ -- DB HiTek, a leading foundry specialist in South Korea, is enhancing its global shutter and single-photon avalanche diode (SPAD) process technologies, which are highly utilized in the automotive, industrial, robotics, and medical fields, to expand its specialized image sensor business.

The global shutter is a sensor that captures images of fast-moving objects without distortion. The demand for global shutters is rapidly increasing in various fields, including machine vision, automotive, drones, robotics, and medical devices, with an expected annual average market growth rate of 16% from 2022 to 2029.

DB HiTek's 7 Tr charge domain global shutter achieves PLS?35,000 at 5.6 um pixels using light shield and light guide technologies and supports various sizes down to a minimum of 2.8 um pixels (PLS?10,000).

Parasitic light sensitivity (PLS) is a concept indicating sensitivity to light, and a PLS of 10,000 or higher demonstrates a shutter efficiency level significantly high enough to achieve a light detection rate of 99.99% (with a noise occurrence rate of less than one in 10,000).

DB HiTek's 6 Tr charge domain global shutter has secured PLS ?10,000 and a memory dark current ?20e/s at 60C in the 2.8 ?m pixel. This process is expected to be completed and provided to customers by the end of this year.

SPAD is an ultra-high-sensitivity 3D image sensor that detects weak light signals at the particle level. It has high precision and allows for long-distance measurement, making it a key component in implementing future advanced technologies such as autonomous vehicles, AR/VR devices, robotics, and smartphones.

DB HiTek's second-generation SPAD process, utilizing a backside scattering technology (BST) and backside deep trench isolation (BDTI) in a BSI structure, achieves an advanced technological level with a photon detection probability of 15.8% at a wavelength of 940 nm. In addition, it ensures improved quality by securing a dark current rate (DCR) performance equivalent to 0.69 cps/um2, corresponding to the dark current of a typical CIS.

Building on the upgraded global shutter and second-generation SPAD process, DB HiTek plans to actively support fabless customers in expanding their specialized image sensor business.

A DB HiTek official said, "Currently, our company is collaborating with leading global companies in the United States, Europe, China, Japan, and other regions to develop products," adding, "We plan to enhance customer support by providing services such as customized processes, TDK for pixel development simulations, as well as multi-layer mask (MLM)."

Meanwhile, DB HiTek has recently expanded its X-ray CIS business by successfully developing products in collaboration with a leading medical sensor specialist in Europe. It is reported that the advanced quality and yield characteristics lead positive response from the customer, and the company will expand its business into the manufacturing sector following the medical field.

About DB HiTek                     

Headquartered in South Korea, DB HiTek Co., Ltd. is world leader in specialty foundry with a broad range of support services plus a robust portfolio of competitive process technologies that include Analog/Power(BCDMOS), CMOS Image Sensor(CIS), Mixed-Signal, High Voltage CMOS, RF HRS/SOI CMOS, Super Junction MOSFET technologies. For more information, visit www.dbhitek.com.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: